4,4,5,5-Tetramethyl-2-(3-perylenyl)-1,3,2-dioxaborolane>97.0%(GC)1g

(4S,4'S)-1,1'-Bis(4-(tert-butyl)phenyl)-4,4'-diisopropyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 100mg

6-Chloro-3-indoxyl-β-D-glucuronic acid cyclohexylammonium salt, 10mg, >=98%

Dithizone, min. 85%, pa, ACS, 25 g, glass packaging

2-(5-Aminopyridin-2-yl)propan-2-ol, 98%, 100mg

(S)-2-Amino-3-(o-tolyl)propanoic acid, 95.0%, 25g

2-Fluoro-N-methylaniline, 98.0%, 5g

1-tert-Butyl 2-ethyl 5-hydroxypiperidine-1,2-dicarboxylate, 95%, 500mg

1,3-Dimethyl-5-pyrazolone>98.0%(HPLC)(T)100g

3,5-Dichloro-4-methylbenzoic acid, 95.0%, 25g

4-[7,12,17-tris(4-chlorophenyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1�,?.1?,��.1��,�?]tetracosa-1,3,5,7,9,11,13(22),14,16,18(21),19-undecaen-2-yl]phenol, 95%, 1g

(S)-Ethyl 2-acetamido-3-phenylpropanoate, 95.0%, 25g

tert-Butyl (2-chloro-4-formylpyridin-3-yl)carbamate, 95+%, 250mg